Cizzle Biotechnology Holdings Stock One Year Return
| CIZ Stock | 1.75 0.05 2.78% |
Cizzle Biotechnology Holdings fundamentals help investors to digest information that contributes to Cizzle Biotechnology's financial success or failures. It also enables traders to predict the movement of Cizzle Stock. The fundamental analysis module provides a way to measure Cizzle Biotechnology's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cizzle Biotechnology stock.
Cizzle | One Year Return |
Cizzle Biotechnology Holdings Company One Year Return Analysis
Cizzle Biotechnology's One Year Return is the annualized return generated from holding a security for exactly 12 months. The measure is considered to be good short-term measures of fund performance. In other words, it represents the capital appreciation of fund investments over the last year. However when the market is volatile such as in recent years, One Year Return measure can be misleading.
More About One Year Return | All Equity Analysis
One Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although One Year Fund Return indicator can give a sense of overall fund short-term potential, it is recommended to look at mid and long term return measure before selecting a particular fund or ETF. The great way to validate fund short-term performance is to compare it with other similar funds or ETFs for the same 12 months interval.
| Competition |
Based on the recorded statements, Cizzle Biotechnology Holdings has an One Year Return of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United Kingdom stocks average (which is currently at 0.0).
Did you try this?
Run CEOs Directory Now
CEOs DirectoryScreen CEOs from public companies around the world |
| All Next | Launch Module |
Cizzle Fundamentals
| Return On Equity | -1.58 | ||||
| Return On Asset | -0.32 | ||||
| Current Valuation | 6.12 M | ||||
| Shares Outstanding | 396.39 M | ||||
| Shares Owned By Insiders | 43.65 % | ||||
| Price To Book | 8.74 X | ||||
| Price To Sales | 200.48 X | ||||
| Gross Profit | 25 K | ||||
| EBITDA | (695) | ||||
| Net Income | (1.76 M) | ||||
| Total Debt | 186 K | ||||
| Book Value Per Share | 0 X | ||||
| Cash Flow From Operations | (639 K) | ||||
| Earnings Per Share | (0.01) X | ||||
| Beta | 0.37 | ||||
| Market Capitalization | 6.94 M | ||||
| Total Asset | 1.69 M | ||||
| Retained Earnings | (7.87 M) | ||||
| Working Capital | 1.51 M | ||||
| Net Asset | 1.69 M |
About Cizzle Biotechnology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cizzle Biotechnology Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cizzle Biotechnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cizzle Biotechnology Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Cizzle Stock
Cizzle Biotechnology financial ratios help investors to determine whether Cizzle Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cizzle with respect to the benefits of owning Cizzle Biotechnology security.